MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Suicide risk relationship with motor and non-motor symptoms in patients with Parkinson’s disease.

    I. Estrada-Bellmann, A. Ontiveros -Sanchez, R. Trejo-Ayala, G. Porras-Garza, L. Dela Garza, G. Sanchez-Torres, R. Ruiz-Meza, P. Cortes-Estrada (MONTERREY, Mexico)

    Objective: Determine Suicide Risk relationship with motor and non motor symptoms in patients with Parkinson´s disease. Background:  Suicidal ideation is increased in people with Parkinson's…
  • 2024 International Congress

    Reduced Thalamic Nuclei Volume May Contribute to Anxiety in Parkinson’s Disease: a 7-Tesla MRI Study

    G. Carey, M. Kuijf, S. Michielse, A. Wolters, K. Dujardin, A. Leentjens (Lille, France)

    Objective: To identify changes in volume of the thalamus and its subnuclei in patients with Parkinson's disease (PD) related anxiety. Background: PD-related anxiety occurs frequently…
  • 2024 International Congress

    Modeling the Role of Parkinson’s Disease-Specific Factors in Depression and Anxiety: Findings from MEX-PD Cohort

    P. Reyes-Pérez, D. Martínez, I. Estrada-Bellmann, C. Guerra-Galicia, N. Gandarilla-Martínez, E. Morelos Figaredo, K. Salinas-Barboza, Y. Matuk-Pérez, A. Lazaro-Figueroa, M. Rentería, S. Alcauter-Solorzano, A. Ruiz-Contreras, A. Medina-Rivera (Queretaro, Mexico)

    Objective: This study, conducted within the Mexican Parkinson’s Disease Research Network (MEX-PD), aims to explore whether depression and anxiety in PD patients primarily stem from…
  • 2024 International Congress

    Subjective Sleep Quality and Pathological Sleepiness in Veterans with Parkinson’s Disease

    A. Sarwar (PEARLAND, USA)

    Objective: To determine the subjective sleep quality and its association with pathological sleepiness in Veterans with Parkinson's disease (PD). Background: Sleep quality issues and pathological…
  • 2024 International Congress

    Assessing the Accuracy of Clinical features, CSF Dopamine Metabolites, and Striatal Binding Ratios for the Likelihood of Depression Over 10-year Follow Up in the PPMI Cohort.

    J. Li, A. Basu, C. Song, I. Bedoy, J. Ruiz Tejeda, S. Nguyen, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: To identify whether MDS-UPDRS scores, Dopamine Transporter (DaT) Striatal Binding Ratios (SBRs), or dopamine metabolites cerebrospinal fluid (CSF) concentrations could predict the likelihood of…
  • 2024 International Congress

    Apathy in de novo Parkinson’s disease improves after the first years with dopaminergic treatment.

    A. Castrioto, M. Anheim, E. Schmitt, S. Meoni, JL. Houeto, H. Klinger, D. Sourd, P. Pelissier, E. Lhommee, C. Tranchant, JP. Azulay, F. Durif, E. Moro, V. Fraix, S. Thobois, P. Krack (Grenoble, France)

    Objective: to define the evolution of apathy and other neuropsychiatric symptoms in patients with early Parkinson’s disease (PD). Background: Apathy is a common neuropsychiatric symptom…
  • 2024 International Congress

    Aberrant connectivity in Resting-State Brain Networks Underlying Neuropsychiatric Symptoms in Prodromal Lewy Body Dementia.

    L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, H. Sigurdsson, J. Schumacher, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)

    Objective: This study aimed to determine the functional neural correlates of neuropsychiatric symptoms (NPS), including mood disorders, anxiety and psychosis, in prodromal Lewy body dementia (LBD)…
  • 2024 International Congress

    Characterizing Dopaminergic Correlates of Depression in Parkinson’s Disease: The PPMI Cohort

    C. Song, A. Basu, I. Bedoy, J. Li, J. Ruiz Tejeda, S. Nguyen, R. Rajmohan, N. Phielipp (Irvine, USA)

    Objective: We explored the association between cerebrospinal fluid (CSF) dopamine metabolites and transporter denervation in the development of depression in Parkinson Disease (PD). Background: Depression…
  • 2024 International Congress

    Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease

    O. Lawal, M. Morales, S. Shakya, J. Savitt, S. Reich, A. Gruber-Baldini, L. Shulman, R. von Coelln (Baltimore, USA)

    Objective: To analyze longitudinal trends of severity of anxiety and depression in a large Parkinson’s Disease (PD) cohort Background: •Depression and anxiety are common non…
  • 2024 International Congress

    Association of insomnia with levodopa-related parameters in Parkinson’s disease

    L. Atabekyan, N. Nadryan, E. Balian, H. Karkourian, H. Hovakimyan, Z. Tavadyan, S. Khachatryan (Yerevan, Armenia)

    Objective: With this analysis we aimed to study the role of insomnia (both sleep onset and sleep maintenance insomnias) in Parkinson’s disease (PD) in relation…
  • « Previous Page
  • 1
  • …
  • 303
  • 304
  • 305
  • 306
  • 307
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley